Fundraising FoxORF Biologics
Coralville, US · Founded 2024 · Iowa corporation
Find your way into ORF Biologics
Each arrow is one introduction. Sign up to fill in the first one.
64 people can intro you to Anant
Ask John Pantazis to introduce you to Anant Kamath
You →John · together at University of Iowa College of Law →Anant
Sign up to find every way you can get introduced to ORF Biologics
- Your email: who you already know at ORF Biologics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ORF Biologics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
ST
Sara TernesExecutive
SH
Stephen HansonExecutive
AK
Anant KamathExecutiveAnant Kamath is Chief Executive Officer of ORF Biologics, which manufactures complex peptides, proteins, and antibodies in GLP and GMP environments. With nearly 40 years of experience in biologics and cellular engineering, he brings technical operations expertise in scaling production across multiple host systems.
NT
Nicholas TaiberNamed on SEC filing
RA
Roger A. BakerNamed on SEC filing
JR
John R. HuiskampNamed on SEC filing
Board
SM
Steven MichalicekBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 of 2 rounds · 2024–2026
▶$1.7MraisedJul 2026 · 17 investors · BiotechnologyRule 506(b)
▶$1.7MraisedJul 2026 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MichalicekDirector
- Anant KamathExecutive Officer, Director
- Jay KamathExecutive Officer
- Sara TernesExecutive Officer
- Nicholas TaiberDirector
- Roger A. BakerDirector
- John R. HuiskampDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Jul 2026
- Incorporated
- Corporation, Iowa, 2024
- Federal exemptions
- 06b
▶$2.5MofferedDec 2024 · BiotechnologyRule 506(b)
▶$2.5MofferedDec 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MichalicekDirector
- Jay KamathExecutive Officer, Director
- Sara TernesExecutive Officer, Director
- Stephen HansonExecutive Officer, Director
- Anant KamathExecutive Officer, Director
- Offering amount
- $2.5M
- Minimum investment
- $50K
- Incorporated
- Corporation, Iowa, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ORF Biologics raised?
- ORF Biologics has disclosed $1.7M raised across 1 of its 2 known rounds.
- Where is ORF Biologics headquartered?
- ORF Biologics is headquartered in Coralville, US.